Integrated delivery device for continuous glucose sensor

  • US 9,050,413 B2
  • Filed: 04/30/2012
  • Issued: 06/09/2015
  • Est. Priority Date: 02/26/2004
  • Status: Active Grant
First Claim
Patent Images

1. An integrated diabetes management system for selectively switching between fully-automated and semi-automated modes, the system comprising:

  • a glucose sensor, wherein the glucose sensor is configured to substantially continuously measure glucose concentration in a host for a period exceeding one hour, and is configured to output a data stream, including one or more sensor data points; and

    a processor module operably connected to the glucose sensor, wherein the processor module that receives the data stream calculates a therapy comprising instructions for administration of a medicament and sends the instructions to a medicament delivery device, wherein the processor module operates the integrated system in a fully-automated mode unless a semi-automated mode is triggered, wherein the fully automated mode does not require user interaction to send instructions to the medicament delivery device, wherein the semi-automated mode requires user interaction before sending instructions to the medicament delivery device, and wherein the semi-automated mode is automatically triggered responsive the processor module detecting a clinical risk.

View all claims

    Thank you for your feedback